Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fulminant hepatic failure

R J Fingerote1, V G Bain

  • 1Department of Medicine, University of Alberta, Edmonton, Canada.

The American Journal of Gastroenterology
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Fulminant hepatic failure (FHF) is a severe condition with historically poor outcomes. Advances in liver transplantation and intensive care have significantly improved survival rates for FHF patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rotterdam score predicts early mortality in Budd-Chiari syndrome, and surgical shunting prolongs transplant-free survival.

Alimentary pharmacology & therapeutics·2009
Same author

Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapy.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2009
Same author

Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirin.

Alimentary pharmacology & therapeutics·2008
Same author

Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3.

Journal of viral hepatitis·2007
Same author

Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders.

Alimentary pharmacology & therapeutics·2007
Same author

Systematic review: renal and other clinically relevant outcomes in hepatorenal syndrome trials.

Alimentary pharmacology & therapeutics·2007
Same journal

Calendar of Courses, Symposiums and Conferences.

The American journal of gastroenterology·2026
Same journal

Molecular Nonendoscopic Tests for the Early Detection of Esophageal Squamous Carcinoma and High-Grade Dysplasia: Promising Progress.

The American journal of gastroenterology·2026
Same journal

ACG Clinical Guideline: Colonic Diverticulitis.

The American journal of gastroenterology·2026
Same journal

Continuing Medical Education Questions: July 2026.

The American journal of gastroenterology·2026
Same journal

Continuing Medical Education Questions: July 2026.

The American journal of gastroenterology·2026
Same journal

2026 CME Information.

The American journal of gastroenterology·2026
See all related articles

Area of Science:

  • Hepatology
  • Critical Care Medicine
  • Transplantation Surgery

Background:

  • Fulminant hepatic failure (FHF) is acute liver failure without prior chronic liver disease.
  • Historically, FHF carried a very poor prognosis.
  • Recent advancements have improved patient survival rates.

Purpose of the Study:

  • To discuss the clinical manifestations of FHF.
  • To review the management strategies for FHF.
  • To explore future prospects in FHF treatment.

Main Methods:

  • Review of clinical manifestations.
  • Discussion of current management protocols.
  • Analysis of treatment individualization based on etiology.
  • Exploration of emerging therapeutic options.

Related Experiment Videos

Main Results:

  • Orthotopic liver transplantation is a viable therapy for liver failure.
  • Intensive care medicine has dramatically improved patient survival.
  • Prognosis is dependent on the underlying cause of FHF.

Conclusions:

  • Treatment requires individualized supportive medical care.
  • Timely referral for orthotopic liver transplantation is crucial.
  • Future prospects involve continued advancements in FHF management.